RCM

RA Capital Management Portfolio holdings

AUM $5.94B
This Quarter Return
-6.87%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$6.23B
AUM Growth
+$6.23B
Cap. Flow
+$768M
Cap. Flow %
12.33%
Top 10 Hldgs %
46.21%
Holding
101
New
19
Increased
9
Reduced
3
Closed
9

Top Buys

1
JANX icon
Janux Therapeutics
JANX
$216M
2
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
$189M
3
DAWN icon
Day One Biopharmaceuticals
DAWN
$113M
4
LENZ
LENZ Therapeutics
LENZ
$82.9M
5
CNTB
Connect Biopharma
CNTB
$78.1M

Top Sells

1
NVAX icon
Novavax
NVAX
$93.9M
2
ADVM icon
Adverum Biotechnologies
ADVM
$92.3M
3
IGMS
IGM Biosciences
IGMS
$75.4M
4
CNST
Constellation Pharmaceuticals, Inc.
CNST
$52.4M
5
TGTX icon
TG Therapeutics
TGTX
$50.2M

Sector Composition

1 Healthcare 97.5%
2 Financials 0.5%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PRDS
76
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$9.98M 0.16%
1,000,000
– –
TXMD icon
77
TherapeuticsMD
TXMD
$12.7M
$9.3M 0.15%
7,812,500
– –
CGEM icon
78
Cullinan Oncology
CGEM
$456M
$9.01M 0.14%
350,000
– –
COGT icon
79
Cogent Biosciences
COGT
$1.83B
$8.32M 0.13%
1,025,641
– –
BMEA icon
80
Biomea Fusion
BMEA
$114M
$7.81M 0.13%
+500,000
New +$7.81M
CVRX icon
81
CVRx
CVRX
$204M
$7.7M 0.12%
+275,000
New +$7.7M
FVAM
82
DELISTED
5:01 Acquisition Corp. Class A Common Stock
FVAM
$7.48M 0.12%
750,000
– –
MLTX icon
83
MoonLake Immunotherapeutics
MLTX
$3.78B
$7.25M 0.12%
700,000
– –
OBIO icon
84
Orchestra BioMed
OBIO
$147M
$6.38M 0.1%
625,000
– –
VRDN icon
85
Viridian Therapeutics
VRDN
$1.59B
$5.71M 0.09%
312,328
– –
SYRS
86
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$4.91M 0.08%
900,000
– –
WHWK
87
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
$4.55M 0.07%
+2,693,309
New +$4.55M
CEREW
88
DELISTED
Cerevel Therapeutics Holdings, Inc. Warrant
CEREW
$3.36M 0.05%
233,333
– –
NTLA icon
89
Intellia Therapeutics
NTLA
$1.26B
$2.43M 0.04%
+15,000
New +$2.43M
ELVN icon
90
Enliven Therapeutics
ELVN
$1.24B
$1.97M 0.03%
248,804
– –
MCRB icon
91
Seres Therapeutics
MCRB
$162M
$1.9M 0.03%
5,105,547
+1,411,354
+38% +$525K
OKUR
92
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$38.3M
$580K 0.01%
+62,217
New +$580K
PRQR icon
93
ProQR Therapeutics
PRQR
$256M
– –
-2,117,669
Closed -$14M
IGMS
94
DELISTED
IGM Biosciences
IGMS
– –
-982,723
Closed -$75.4M
ADVM icon
95
Adverum Biotechnologies
ADVM
$68.2M
– –
-9,365,833
Closed -$92.3M
CNST
96
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
– –
-2,238,536
Closed -$52.4M
XFOR icon
97
X4 Pharmaceuticals
XFOR
$70M
– –
-536,962
Closed -$4.62M
STRO icon
98
Sutro Biopharma
STRO
$85.6M
– –
-2,118,212
Closed -$48.2M
SNDX icon
99
Syndax Pharmaceuticals
SNDX
$1.39B
– –
-1,023,067
Closed -$22.9M
RPTX icon
100
Repare Therapeutics
RPTX
$73.9M
– –
-409,000
Closed -$12.6M
1 2 3
4
5